%0 Journal Article %A Erik Rosenstrom %A Jessica Mele %A Julie Ivy %A Maria Mayorga %A Mehul Patel %A Kristen Hassmiller Lich %A Paul Delamater %A Raymond Smith %A Julie L. Swann %T Vaccinating Children Against COVID-19 is Essential Prior to the Removal of Non-Pharmaceutical Interventions %D 2021 %R 10.1101/2021.12.08.21267496 %J medRxiv %P 2021.12.08.21267496 %X Objectives(s) To evaluate the joint impact of childhood vaccination rates and masking policies, in schools and workplaces, on community transmission and severe outcomes due to COVID-19.Study design We utilized a stochastic, agent-based simulation of North Carolina, to evaluate the impact of 24 health policy decisions on overall incidence of disease, COVID-19 related hospitalization, and mortality from July 1, 2021-July 1, 2023.Results Universal mask removal in schools in January 2022 could lead to a 38.1-47%, 27.6-36.2%, and 15.9-19.7% increase in cumulative infections for ages 5-9, 10-19, and the total population, respectively, depending on the rate of vaccination of children relative to the adult population. Additionally, without increased vaccination uptake in the adult population, a 25% increase in child vaccination uptake from 50% to 75% uptake and from 75% to 100% uptake relative to the adult population, leads to a 22% and 18% or 28% and 33% decrease in peak hospitalizations in 2022 across scenarios when masks are removed either January 1st or March 8th 2022, respectively. Increasing vaccination uptake for the entire eligible population can reduce peak hospitalizations in 2022 by an average of 89% and 92% across all masking scenarios compared to the scenarios where no children are vaccinated.Conclusion(s) High vaccination uptake among both children and adults is necessary to mitigate the increase in infections from mask removal in schools and workplaces.Competing Interest StatementDr Patel reported receiving grants from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) and from the Council of State and Territorial Epidemiologists (CSTE) during the conduct of the study. Mr Rosenstrom reported receiving grants from the Centers for Disease Control and Prevention (CDC) and Translational and Clinical Sciences during the conduct of the study. Ms. Mele reported receiving support from the CDC, CSTE, and NCATS/NIH during the conduct of the study. Dr Ivy reported receiving grants from the CSTE and CDC-Prime and a University of North Carolina/North Carolina State Translational Research Grant during the conduct of the study. Dr Mayorga reported receiving grants from the NCATS/NIH, CSTE, and CDC during the conduct of the study. Dr Swann reported receiving grants from the Department of Health and Human Services, NCATS/NIH, and CSTE during the conduct of the study. No other disclosures were reported.Funding StatementThis research was supported by grant UL1TR002489 from the NCATS/NIH; Cooperative Agreement NU38OT000297 from the CSTE and the CDC; and grant K01AI151197 from the National Institute of Allergy and Infectious Diseases/NIH (Dr Delamater).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis manuscript uses publicly available data from the US Census, published estimates of disease parameters, and data obtained from North Carolina department of Health on age-based vaccination rates. The Institutional Review Board of NC State reviewed the project and determined that no IRB approval would be needed since identifiers are not included with the dataset and individuals cannot be directly or indirectly identified. %U https://www.medrxiv.org/content/medrxiv/early/2021/12/09/2021.12.08.21267496.full.pdf